RecruitingPhase 2NCT05644184

Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
PATH
Principal Investigator
K. Zaman, MBBS, MPH, PhD, FRCP
International Centre for Diarrhoeal Disease Research, Bangladesh
Intervention
Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1)(biological)
Enrollment
2232 target
Eligibility
4 years · All sexes
Timeline
2023 – 2026

Study locations (1)

Collaborators

Bill and Melinda Gates Foundation · PT Bio Farma · Centers for Disease Control and Prevention · DiagnoSearch Life Sciences Pvt. Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05644184 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis →

← Back to all trials